(Q34552904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

review article

1 reference

title

AIDS-related tumors: integrating antiviral and anticancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Umberto Tirelli

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Daniele Bernardi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Emanuela Vaccher

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Oncology Hematology

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

299-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

AIDS-related malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Malignant lymphomas in a population at risk for acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Unusual malignant tumours in 49 patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Neoplastic complications of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Increased Incidence of Hodgkin Disease in Homosexual Men with HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Multistate AIDS/Cancer Match Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Risk of cancer in people with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

The epidemiology of acquired immunodeficiency syndrome and associated tumours in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Clinical aspects of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Kaposi's sarcoma: advances and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Treatment of the acquired immune deficiency syndrome—related Kaposi's sarcoma with bleomycin as a single agent

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

The epidemiology of acquired immunodeficiency syndrome-related lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with othe

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Acquired immune deficiency syndrome-related pulmonary non-Hodgkin lymphoma regressing after zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Azothymidine and interferon-alpha are active in AIDS-associated small non-cleaved cell lymphoma but not large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Complete remission of a primary effusion lymphoma with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Ongoing HIV dissemination during HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Hodgkin's disease in 92 patients with HIV infection: The Italian experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Human immunodeficiency virus infection and cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Risk of invasive cervical cancer among women with, or at risk for, HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Histology/cytology discrepancies in HIV-infected obstetric patients with normal pap smears

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Randomized double-blind trial of beta-carotene and vitamin C in women with minor cervical abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Systemic α-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: Double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Cervical cancer as an AIDS-defining illness

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Human immunodeficiency virus infection and genital warts as risk factors for anal intraepithelial neoplasia in homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

ASSOCIATION BETWEEN ANORECTAL DYSPLASIA, HUMAN PAPILLOMAVIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HOMOSEXUAL MEN

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Sexual practices, sexually transmitted diseases, and the incidence of anal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

The epidemiology of AIDS--related neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Spectrum of AIDS-associated malignant disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Anal neoplasia. Pathogenesis, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Anal cytology as a screening tool for anal squamous intraepithelial lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Anal and cervical abnormality in women--prediction by human papillomavirus tests

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Nonmelanoma skin cancers and infection with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Therapy of non-small-cell lung cancer (NSCLC) in patients with HIV infection. GICAT. Cooperative Group on AIDS and Tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

Testicular germ cell tumors and human immunodeficiency virus infection: a report of 26 cases. Italian Cooperative Group on AIDS and Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900165-2

7 January 2021

10.1016/S1040-8428(01)00165-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880206%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference